Reclast (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Reclast drug offered from Novartis Pharmaceuticals Corporation. This Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | zoledronic acid |
| SUBSTANCE NAME: | ZOLEDRONIC ACID |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2007-04-01 |
| END MARKETING DATE: | 0000-00-00 |
Reclast HUMAN PRESCRIPTION DRUG Details:
| Item Description | Reclast from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/100mL) |
| START MARKETING DATE: | 2007-04-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0435_11574d9e-8384-4121-b7f4-e25cf0e31ecd |
| PRODUCT NDC: | 0078-0435 |
| APPLICATION NUMBER: | NDA021817 |
Other ZOLEDRONIC ACID Pharmaceutical Manufacturers / Labelers:
